about
Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...
Read More
1905.60
-19.20
(-1.00%)
577.0K
NSE+BSE Volume
NSE 08 Oct, 2025 3:31 PM (IST)
US FDA Observation
Lupin gets Form 483 with four observations from the US FDA for its Pithampur manufacturing facility
See details